Cynthia J. Davenport, Ph.D., President, is an expert pharmaceutical toxicologist having over 24 years of experience with global, multi-disciplinary drug development teams, toxicology, drug safety, study directing, regulatory strategy, medical writing, and project management. She has a strong background in supervisory and project management roles within multiple therapeutic areas (human and veterinary). Dr. Davenport has managed drug candidates from early through advanced phases of development in a diverse, matrixed environment at legacy Pfizer (almost 17 years) and through consulting. She has a solid track record of problem solving and problem prevention. Dr. Davenport is a strong team player, both as an individual contributor and in a leadership role. Her leadership style is goal driven and results oriented. Additional Specialties General / Regulatory Toxicology • Integrated Nonclinical Safety Summary • Nonclinical / Preclinical • Drug Safety Strategy • IND Enabling Studies • CRO Selection • Study Design, Placement, and Monitoring • Impurity / Metabolite Qualification • Team Involvement / Leadership • Regulatory Document Preparation • eCTD • Investigator Brochures (IB) • Expert Report • White Paper Preparation • Manuscript Preparation • Academic Liaison • Peer Review • QC • Literature Review